<VariationArchive RecordType="classified" VariationID="417313" VariationName="NC_000019.10:g.(?_1218417)_(1223172_?)del" VariationType="Deletion" Accession="VCV000417313" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2017-04-17" MostRecentSubmission="2017-04-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="402833" VariationID="417313">
      <GeneList>
        <Gene Symbol="LOC110006318" FullName="serine/threonine kinase 11 intron 3 Alu-mediated recombination region" GeneID="110006318" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="1219531" stop="1219844" display_start="1219531" display_stop="1219844" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130062899" FullName="ATAC-STARR-seq lymphoblastoid active region 13597" GeneID="130062899" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="1223046" stop="1223255" display_start="1223046" display_stop="1223255" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="STK11" FullName="serine/threonine kinase 11" GeneID="6794" HGNC_ID="HGNC:11389" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="1205778" stop="1228431" display_start="1205778" display_stop="1228431" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="1205797" stop="1228433" display_start="1205797" display_stop="1228433" Strand="+" />
          </Location>
          <OMIM>602216</OMIM>
          <Haploinsufficiency last_evaluated="2021-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=STK11">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=STK11">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NC_000019.10:g.(?_1218417)_(1223172_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" innerStart="1218417" innerStop="1223172" display_start="1218417" display_stop="1223172" variantLength="4756" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" innerStart="1218416" innerStop="1223171" display_start="1218416" display_stop="1223171" variantLength="4756" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.(?_1218417)_(1223172_?)del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.(?_1218417)_(1223172_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.(?_1218416)_(1223171_?)del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.(?_1218416)_(1223171_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000019.10:g.(?_1218417)_(1223172_?)del AND Peutz-Jeghers syndrome" Accession="RCV000467252" Version="1">
        <ClassifiedConditionList TraitSetID="2024">
          <ClassifiedCondition DB="MedGen" ID="C0031269">Peutz-Jeghers syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-09-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-09-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-04-17" MostRecentSubmission="2017-04-17">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="2024" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5754" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Periorificial lentiginosis syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lentiginosis, perioral</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyposis, hamartomatous intestinal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyps-and-spots syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peutz-Jeghers polyposis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peutz-Jeghers syndrome</ElementValue>
                <XRef ID="Peutz+Jeghers+syndrome/5695" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008280" DB="MONDO" />
                <XRef ID="54411001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PJS</ElementValue>
                <XRef Type="MIM" ID="175200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Peutz-Jeghers syndrome (PJS) is characterized by the association of gastrointestinal (GI) polyposis, mucocutaneous pigmentation, and cancer predisposition. PJS-type hamartomatous polyps are most common in the small intestine (in order of prevalence: jejunum, ileum, and duodenum) but can also occur in the stomach, large bowel, and extraintestinal sites including the renal pelvis, bronchus, gall bladder, nasal passages, urinary bladder, and ureters. GI polyps can result in chronic bleeding, anemia, and recurrent obstruction and intussusception requiring repeated laparotomy and bowel resection. Mucocutaneous hyperpigmentation presents in childhood as dark blue to dark brown macules around the mouth, eyes, and nostrils, in the perianal area, and on the buccal mucosa. Hyperpigmented macules on the fingers are common. The macules may fade in puberty and adulthood. Recognition of the distinctive skin manifestations is important especially in individuals who have PJS as the result of a de novo pathogenic variant as these skin findings often predate GI signs and symptoms. Individuals with PJS are at increased risk for a wide variety of epithelial malignancies (colorectal, gastric, pancreatic, breast, and ovarian cancers). Females are at risk for sex cord tumors with annular tubules (SCTAT), a benign neoplasm of the ovaries, and adenoma malignum of the cervix, a rare aggressive cancer. Males occasionally develop large calcifying Sertoli cell tumors of the testes, which secrete estrogen and can lead to gynecomastia, advanced skeletal age, and ultimately short stature, if untreated.</Attribute>
                <XRef ID="NBK1266" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7378" />
                <XRef ID="7378" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301443</ID>
                <ID Source="BookShelf">NBK1266</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2013">
                <ID Source="pmc">3585492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2020">
                <ID Source="PubMed">31672839</ID>
                <ID Source="pmc">7295005</ID>
              </Citation>
              <XRef ID="2869" DB="Orphanet" />
              <XRef ID="C0031269" DB="MedGen" />
              <XRef ID="D010580" DB="MeSH" />
              <XRef ID="MONDO:0008280" DB="MONDO" />
              <XRef Type="MIM" ID="175200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1076691" SubmissionDate="2017-03-14" DateLastUpdated="2017-04-17" DateCreated="2017-04-17">
        <ClinVarSubmissionID localKey="1034177|MedGen:C0031269" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000563774" DateUpdated="2017-04-17" DateCreated="2017-04-17" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-09-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment Type="public">This variant is a gross deletion of the genomic region encompassing exons 2-8 of the STK11 gene. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated or disrupted STK11 protein. Loss-of-function variants including gross deletions in STK11 are known to be pathogenic. Deletion of exons 2-8 has been reported in an individual with Peutz-Jeghers syndrome (PJS) in the Leiden Open-source Variation Database (PMID: 21520333). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="STK11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.(?_1218416)_(1223171_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0031269" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2017March_Invitae</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1076691" TraitType="Disease" MappingType="XRef" MappingValue="C0031269" MappingRef="MedGen">
        <MedGen CUI="C0031269" Name="Peutz-Jeghers syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

